Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Nippon Soda Group ESG Data Book 2025
Nippon Soda Group Integrated Report 2025
Notice Concerning Changes in Executive Officers and Important Employee
Notice Concerning Absorption-type Merger of Consolidated Subsidiary (Simplified Merger and Short-form Merger)
Notice of Additional Investment in SENTAN Pharma Inc.
Notice Concerning Status of Acquisition of Treasury Shares
Nippon Soda, First Half Ordinary Profit Unexpectedly Revised Upward by 16%
Consolidated Financial Results for the Six Months Ended September 30, 2025 (Under Japanese GAAP)
Notice Concerning Difference between Consolidated Financial Forecasts and Actual Results for the First Half of the Fiscal Year Ending March 31, 2026
Financial Results Summary for the 2nd Quarter of the Fiscal Year Ending March 31, 2026
Notice Concerning Status of Acquisition of Treasury Shares
Notice Concerning Status of Acquisition of Treasury Shares
Joint Research Agreement ConcludedSigned with MabGenesis Inc. for Novel Monoclonal Antibody Therapeutics for Dogs and Cats
Notice Concerning Status of Acquisition of Treasury Shares
Consolidated Financial Results for the Three Months Ended June 30, 2025(Under Japanese GAAP)
Nippon Soda, Apr-Jun (1Q) Ordinary Profit Decreases by 13%
Financial Results Summary for the 1st Quarter of the Fiscal Year Ending March 31, 2026
Joint Research and Development Agreement with KAICO Ltd. for Veterinary Pharmaceuticals
Notice Concerning Status of Acquisition of Treasury Shares
Notice Concerning Completion of Payment for Disposal of Treasury Shares as Restricted Share Remuneration